[go: up one dir, main page]

NO995500D0 - Use of a pharmaceutical composition for the treatment of / or prevention of ischemia - Google Patents

Use of a pharmaceutical composition for the treatment of / or prevention of ischemia

Info

Publication number
NO995500D0
NO995500D0 NO995500A NO995500A NO995500D0 NO 995500 D0 NO995500 D0 NO 995500D0 NO 995500 A NO995500 A NO 995500A NO 995500 A NO995500 A NO 995500A NO 995500 D0 NO995500 D0 NO 995500D0
Authority
NO
Norway
Prior art keywords
ischemia
prevention
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
NO995500A
Other languages
Norwegian (no)
Other versions
NO995500L (en
Inventor
Carine Michiels
Original Assignee
Remacle Jose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Remacle Jose filed Critical Remacle Jose
Publication of NO995500D0 publication Critical patent/NO995500D0/en
Publication of NO995500L publication Critical patent/NO995500L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO995500A 1997-05-13 1999-11-10 Use of a pharmaceutical composition for the treatment of / or prevention of ischemia NO995500L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700415A BE1011151A3 (en) 1997-05-13 1997-05-13 Use of a pharmaceutical composition for treating and / or preventing ischemia.
PCT/BE1998/000067 WO1998051291A1 (en) 1997-05-13 1998-05-12 Use of a pharmaceutical composition for treating and/or preventing ischemia

Publications (2)

Publication Number Publication Date
NO995500D0 true NO995500D0 (en) 1999-11-10
NO995500L NO995500L (en) 1999-11-10

Family

ID=3890512

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995500A NO995500L (en) 1997-05-13 1999-11-10 Use of a pharmaceutical composition for the treatment of / or prevention of ischemia

Country Status (7)

Country Link
EP (1) EP0981339A1 (en)
JP (1) JP2001526658A (en)
AU (1) AU7327298A (en)
BE (1) BE1011151A3 (en)
CA (1) CA2287363A1 (en)
NO (1) NO995500L (en)
WO (1) WO1998051291A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792203B1 (en) * 1999-04-19 2003-05-16 Mu Laboratoire NOVEL COMPOSITION BASED ON NATURAL PLANT EXTRACTS, AND ITS USE, PARTICULARLY IN THE PHARMACEUTICAL OR COSMETIC FIELDS
FR2796552A1 (en) * 1999-07-21 2001-01-26 Centre Nat Rech Scient NOVEL USE OF BETA-NAPHTOQUINONE DERIVATIVES AND THEIR SALTS FOR THE MANUFACTURE OF MEDICINES HAVING AN INHIBITOR EFFECT ON THE RELEASE OF GLUTAMATE IN THE BRAIN
FR2802425B1 (en) * 1999-12-21 2003-09-26 Oreal USE OF AN EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY AS AN ANTI-GLYCATION AGENT
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
FR2814950B1 (en) * 2000-10-05 2003-08-08 Oreal USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING
DE10122714A1 (en) * 2001-05-10 2002-11-21 Brench Ag Combination of a rutin and aescin for treating ocular disorders associated with altered blood circulation, e.g. glaucoma or edema
DE10122715A1 (en) * 2001-05-10 2002-11-21 Brench Ag Use of rutines and escines for the treatment of auricular circulatory disorders
EP1382327A1 (en) * 2002-07-17 2004-01-21 Cognis France S.A. Method of protection of the skin against ageing
EP1382326A1 (en) * 2002-07-17 2004-01-21 Cognis France S.A. Method of protecting the skin against ageing
FR2844716B1 (en) * 2002-09-23 2008-11-21 Marcel Jacques Chicouri NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR FOOD HYGIENE OF DIABETICS
JP4562365B2 (en) * 2003-09-19 2010-10-13 株式会社ノエビア Health promotion composition
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
EP1588705A1 (en) * 2004-04-21 2005-10-26 INTE:LIGAND Software-Entwicklungs und Consulting GmbH Use of coumarin derivatives
EP1607006A1 (en) * 2004-06-18 2005-12-21 Unilever N.V. Functional berry composition
EP1959969A2 (en) * 2005-07-01 2008-08-27 The Johns Hopkins University Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
FR2904222A1 (en) 2006-07-27 2008-02-01 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES
KR100880876B1 (en) * 2007-04-11 2009-01-30 경상대학교산학협력단 Pharmaceutical composition for preventing or treating ischemia-reperfusion injury of flap or tissue containing anthocyanin extracted from black bean skin
DE102007033067A1 (en) * 2007-07-13 2009-01-15 Institut für Umweltmedizinische Forschung gGmbH Preparations for improving the protection of human cells, in particular cells of the human skin against damaging influences by oxidative noxious agents and UV irradiation
EP2014276A1 (en) 2007-06-20 2009-01-14 Cognis IP Management GmbH Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD3986C2 (en) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MD4231C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
CN110585222B (en) * 2019-10-12 2023-05-09 西南医科大学 Application of aescin compounds in the preparation of medicines
IT202000010924A1 (en) * 2020-05-13 2021-11-13 Neilos S R L "COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE CIRCULATORY SYSTEM AND RELATED SYMPTOMS"
CN112138015B (en) * 2020-10-22 2022-08-05 合肥博思科创医药科技有限公司 Application of tribenoside in treating skin diseases caused by microcirculation disturbance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623255A1 (en) * 1986-07-10 1988-01-21 Oxo Chemie Gmbh Pharmaceutical composition for preventing oxidative damage to blood vessels
DE3808835A1 (en) * 1987-03-27 1988-10-06 Sandoz Ag Pharmaceutical composition containing a mixture of dihydroergotamine, etilefrine and troxerutin
FR2707495B1 (en) * 1993-07-02 1995-09-01 Roussel Uclaf New use of beta-naphthoquinone derivatives and their salts.
FR2726469B1 (en) * 1994-11-08 1996-12-13 Adir PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS

Also Published As

Publication number Publication date
WO1998051291A1 (en) 1998-11-19
AU7327298A (en) 1998-12-08
EP0981339A1 (en) 2000-03-01
JP2001526658A (en) 2001-12-18
CA2287363A1 (en) 1998-11-19
NO995500L (en) 1999-11-10
BE1011151A3 (en) 1999-05-04

Similar Documents

Publication Publication Date Title
NO995500L (en) Use of a pharmaceutical composition for the treatment of / or prevention of ischemia
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
DK0941103T3 (en) Pharmaceutical preparation for the treatment of diabetes
IS2184B (en) Oral oral dosage form
EE200000468A (en) The compounds, their use and the pharmaceutical composition
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
DK0797991T3 (en) Delayed-release drug formulation
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
NO990594D0 (en) Pharmaceutical surface aerosol composition
ID25543A (en) ALPHA-ARIL-N-ALKINITRON AND THE PHARMACY COMPOSITION CONTAINING IT
TR199800436A3 (en) The use of primidine derivatives for cancer prevention.
BR9701673A (en) Arrangement for the application of a medicinal liquid
NO985539D0 (en) Pharmaceutical surface mixtures
NO995251D0 (en) Procedure for administering halotherapy
DE69812708D1 (en) NEW MEDICAMENT CONTAINING URIDINTRIPHOSPHATE
ITMI950855A0 (en) PROCEDURE FOR THE PROTECTION OF STONE OR COVERING SURFACES
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
ID29294A (en) PHARMACEUTICAL COMPOSITION
NO934832D0 (en) Pharmaceutical composition for the prevention or treatment of arterioscerosis
ID18698A (en) PHARMACEUTICAL COMPOSITION
ID25857A (en) PHARMACEUTICAL COMPOSITION
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
NO983784L (en) Processes for the preparation of biphenyl-isoxazole sulfonamides
NO993549L (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
AP9700928A0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application